6-isopropyl-2-naphthol | 91909-30-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 6-isopropyl-2-naphthol
• 英文别名: 6-i-propyl-2-naphthol；6-isopropylnaphthalen-2-ol；2-hydroxy-6-(1-methylethyl)naphthalene；2-Naphthalenol, 6-(1-methylethyl)-；6-propan-2-ylnaphthalen-2-ol
• CAS: 91909-30-7
• 化学式: C₁₃H₁₄O
• 分子量: 186.254
• InChiKey: MDWFMRLBXKFHHI-UHFFFAOYSA-N

物化性质

• 熔点：
  111.5-112.5 °C
• 沸点：
  321.7±11.0 °C(Predicted)
• 密度：
  1.082±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  6-isopropyl-2-naphthol 在 copper acetylacetonate 、 N-羟基邻苯二甲酰亚胺 、 偶氮二异丁腈 、 硫酸 作用下， 以 苯甲腈 为溶剂， 反应 6.83h， 生成 2-methoxy-6-(1-hydroperoxy-1-methylethyl)naphthalene
  参考文献：
  名称：

  Oxidation of 2-methoxy-6-(1-methylethyl)naphthalene with oxygen

  摘要：

  Aerobic oxidation of 2-methoxy-6-(1-methylethyl)naphthalene to hydroperoxide, alcohol, and ketone, is reported. These compounds, particularly 2-acetyl-6-methoxynaphthalene, are important intermediates in naproxen synthesis. N-Hydroxyphthalimide is shown here to be an efficient catalyst for oxidation to the hydroperoxide, 2-methoxy-6-(1-hydroperoxy-1-methylethyl)naphthalene, with a yield of 87%. However, the ketone and alcohol were obtained with lower yields, with a maximum yield of 13% for the ketone and 27% for the alcohol, using N-hydroxyphthalimide and Cu(II) acetylacetonate as a catalyst. The synthesis of the products 2-acetyl-6-methoxynaphthalene and 2-methoxy-6-(1-hydroxy-1-methylethyl)naphthalene via an initial oxidation step to the hydroperoxide followed by a hydroperoxide decomposition step is shown to be more efficient; the ketone and alcohol were obtained from 2-methoxy-6-(1-methylethyl)naphthalene with yields of 40 and 56%, respectively.

  DOI：

  10.1007/s00706-011-0630-3
• 作为产物：
  描述：

  2-异丙基萘 在 氢氧化钾 、 硫酸 作用下， 生成 6-isopropyl-2-naphthol
  参考文献：
  名称：

  The Total Synthesis of dl-Dehydroabietic Acid

  摘要：

  DOI：

  10.1021/ja00861a031

文献信息

• Raf inhibitor compounds and methods of use thereof
  申请人：Miknis Greg

  公开号：US20070049603A1

  公开（公告）日：2007-03-01

  Compounds of Formula I are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formula I, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

  公式I的化合物对抑制Raf激酶和治疗由此介导的疾病有用。公开了使用公式I的化合物及其立体异构体、几何异构体、互变异构体、溶剂合物和药学上可接受的盐，在哺乳动物细胞中进行体外、体内和体内诊断、预防或治疗此类疾病或相关病理条件的方法。
• Methylation of Arenols through Ni-catalyzed C-O Activation with Methyl Magnesium Bromide
  作者：Wen-Juan Shi、Zhang-Jie Shi

  DOI：10.1002/cjoc.201700664

  日期：2018.3

  Direct alkylation of arenols with alkyl organometallic reagents has never been approached. Herein we reported the first successful example of nickel‐catalyzed methylation of arenols with methyl Grignard reagents to construct C(sp2)‐C(sp3) bond under mild conditions. The transformation was compatible with broad substrate scope of 2‐naphthol derivatives. Benzyl alcohol and biphenols were also suitable

  从未有过使用烷基有机金属试剂将芳烃直接烷基化的方法。在这里，我们报道了第一个成功的例子，该例子是在温和条件下用甲基格氏试剂进行镍催化的芳香烃甲基化，以构建C（sp 2）-C（sp 3）键。该转化与2-萘酚衍生物的广泛底物范围兼容。苄醇和联苯酚也是该甲基化的合适底物。
• Enantioselective Ni-Catalyzed Electrochemical Synthesis of Biaryl Atropisomers
  作者：Hui Qiu、Bin Shuai、Yun-Zhao Wang、Dong Liu、Yue-Gang Chen、Pei-Sen Gao、Hong-Xing Ma、Song Chen、Tian-Sheng Mei

  DOI：10.1021/jacs.9b13117

  日期：2020.6.3

  A scalable enantioselective nickel-catalyzed electrochemical reductive homocoupling of aryl bromides has been developed, affording enantioenriched axially chiral biaryls in good yield under mild conditions using electricity as a reductant in an undivided cell. Common metal reductants such as Mn or Zn powder resulted in significantly lower yields in the absence of electric current under otherwise identical

  已经开发了一种可扩展的对映选择性镍催化的芳基溴化物电化学还原均偶联，在温和的条件下使用电作为未分割电池中的还原剂，以良好的产率提供对映体富集的轴向手性联芳基化合物。在其他条件相同的情况下，在没有电流的情况下，常见的金属还原剂（例如 Mn 或 Zn 粉末）导致产率显着降低，这突显了过渡金属催化和电化学结合提供的增强的反应性。
• Mechanistic Insights into the FeCl₃-Catalyzed Oxidative Cross-Coupling of Phenols with 2-Aminonaphthalenes
  作者：Vlada Vershinin、Hagit Forkosh、Mor Ben-Lulu、Anna Libman、Doron Pappo

  DOI：10.1021/acs.joc.0c00874

  日期：2021.1.1

  The selective FeCl3-catalyzed oxidative cross-coupling reaction between phenols and primary, secondary, and tertiary 2-aminonaphthalene derivatives was investigated. The generality of this scalable method provides a sustainable alternative for preparing N,O-biaryl compounds that are widely used as ligands and catalysts. Based on a comprehensive kinetic investigation, a catalytic cycle involving a ternary

  研究了酚与伯，仲和叔2-氨基萘衍生物之间的选择性FeCl 3催化的氧化交叉偶联反应。这种可扩展方法的通用性为制备广泛用作配体和催化剂的N，O-联芳基化合物提供了一种可持续的选择。基于全面的动力学研究，提出了在关键的氧化偶联步骤中涉及三元配合物的催化循环，该三元配合物与偶联伙伴和氧化剂结合。此外，研究表明，该反应受环外酸碱和配体交换过程的调节。
• [EN] N-CYCLYL-3 - (CYCLYLCARBONYLAMINOMETHYL) BENZAMIDE DERIVATIVES AS RHO KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE N-CYCLYL-3-(CYCLYLCARBONYLAMINOMÉTHYL)BENZAMIDE EN TANT QU'INHIBITEURS DE LA RHO KINASE
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2012006203A1

  公开（公告）日：2012-01-12

  The present invention relates to compounds of formula (I) : and pharmaceutically acceptable salts thereof, wherein R1and R2 are various ring systems. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of Rho Kinase mediated diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

  本发明涉及化合物的公式（I）及其药学上可接受的盐，其中R1和R2是不同的环系统。该发明还涉及包括这些化合物的药物组合物，使用这些化合物治疗Rho激酶介导的疾病和障碍的方法，制备这些化合物的方法以及在这些过程中有用的中间体。